Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 33,00 € Taxes included to order
    Pages Iconography Videos Other
    2 0 0 0

Volume 17, n° S1
pages 101-102 (avril 2008)
Doi : 10.1016/S1158-1360(08)72793-2
T07-O-03 Benign prostatic hyperplasia plus chronic prostatitis - new possibility of treatment

E. Kulchavenya
Urogenital Dpt of Novosibirsk Research TB Institute, Novosibirsk, Russia 


Benign prostatic hyperplasia (BPH) is a common problem of men aged 60 years and above. Enlargement of the prostate can exert pressure on the urethra; resulting is gradual obstruction to urine flow. The expressed violation of urination often is explained also by accompanying prostatitis. So medicine treatment BPH alone is insufficiently effective.

Material and Methods

86 patients with BPH and co-morbidity chronic prostatitis were enrolled in study. Control group (39 patients) received Tamsulosin during 3 months and doxiciclinum for 10 days. Experience group (47 patients) received also laser therapy. Efficiency was assessed using IPSS, uroflowmetry, prostate secretion analysis and bacteriological tests. The first examination was before the treatment, and the final estimation was in 3 months.


In control group symptom scores reduced by 38% and flow rates improved by 24%. In experience group improvement in symptom score and flow rates was 54% and 32% accordingly. In control group 58% patients had signs of prostate inflammation, growth of microbial flora and there were only 16% such patients in experience group. No adverse effects were marked.


Simultaneous application of laser therapy, doxiciclinum and Tamsulosin in patients with co-morbidity BPH and prostatitis resulted in cumulation of antibacterial in a prostate tissue, removal of spasm, facilitation of out flow of a prostate secret and an inflammatory exudate, cupping of dysuria. All the I-PSS scores decreased significantly during the treatment.

The full text of this article is available in PDF format.

© 2008  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline